Eupraxia Pharmaceuticals Inc. EPRX
$5.92
▲ +0.17% 24H
About
Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company dedicated to the development of innovative drug delivery technologies. Its primary focus lies in creating long-lasting medications that address pain management and various chronic diseases. The company's flagship product, EP-104IAR, is being develo…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryCanada
Employees33
TickerEPRX
Statistics
Market Cap$366.2M
Revenue (TTM)$0
Net Income-$38.6M
Net Margin—
EPS$-1.03
P/E-5.85
P/S—
P/B3.37
EV/EBITDA-5.96
ROE-54.5%
Dividend Yield—
Price$5.92
Data: Twelve Data · Revenue = mcap / P/S